http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03054145-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a782bec551e191bfc51138bad8d09636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21dcfd1498a32a0b74430fc648b9ca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe1ad89ad39c7a8da4fa1cb3e3906a1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bd16975a17db0371c2ab59f1b98c712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a789ca29fd8d74024956bd159ad33157
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-30
filingDate 2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071f9d4226795879cc14e465ded991ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc64f68c6b1cb5faf456cbcd716257a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe35207dbac1f053a56c3af70cd427a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f60c51452296ee5639a1d4df588719
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de471f97febc32838080231f75f500ee
publicationDate 2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03054145-A3
titleOfInvention Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
abstract The present invention is related to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of Formula I or a naked ligand of formula II: (Formula I and II).
priorityDate 2001-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341

Total number of triples: 28.